CAS: 158747-02-5; (R)-Frovatriptan

该化合物是5-HT_1B和5-HT_1D受体的选择性抗体,主要用于治疗偏头痛.它属于三联药物类,其特征是它们能够通过抑制脊髓血管和抑制排出亲食性...

结构式图片

MSDS等安全信息

    上下游产品

    (R)-3-[benzyl(Methyl)Amino]-2,3,4,9-Tetrahydro-1H-Carbazole-6-Carboxamide 158747-18-3

    合成工艺路线路线简述

      📜(R)-3-[benzyl(Methyl)Amino]-2,3,4,9-Tetrahydro-1H-Carbazole-6-Carboxamide置于palladium 10% On Activated Carbon,氢气体系中,用 甲醇 用作溶剂,化学反应 1.0H,以71%的收率获得夫罗曲坦
      参考文献:血清素受体激动剂 (R)-Frovatriptan 的化学酶促不对称合成
      标题:血清素受体激动剂 (R)-Frovatriptan 的化学酶促不对称合成
      摘要:已经开发了一种简单的化学酶促不对称途径来生产抗偏头痛药 (R)-Frovatriptan.脂肪酶和氧化还原酶已被确定为在安全和环境友好的条件下生产对映体纯的合成中间体的理想生物催化剂.(S)-3-Hydroxy-2,3,4,9-Tetrahydro-1H-Carbazole-6-Carbonitrile 是该药物合成的最佳结构单元,已通过 Candida Antarctica 脂肪酶 B 型催化酰化其相应的外消旋混合物或醇脱氢酶a介导相应酮的生物还原.手性中心的反转已被确定为关键步骤,优化过程以避免部分外消旋化.最后,
      Doi:10.1002/ejoc.201300114

      海关参考信息

      专利信息


      专利号:US-9353057-B2
      优先权日:2003-12-30
      标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
      发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
      权利人:XENOPORT INC
      摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

      专利号:US-2015158809-A9
      优先权日:2013-02-26
      标 题 :Method of making 1-(acyloxy)-alkyl carbamate compounds
      发明人:WANG HUAN; LIU PENG; DAI QUNYING; YIN HAO; RAILLARD STEPHEN P
      权利人:XENOPORT INC
      摘要:Methods of preparing carbamate prodrugs of amine-containing drugs are provided. Carbonates useful in the synthesis of the carbamate prodrugs are also provided.

      专利号:US-7309799-B2
      优先权日:2004-06-01
      标 题:Methods for the synthesis of milnacipran and congeners thereof
      发明人:BUCHWALD STEPHEN L; SWAGER TIMOTHY M; RARIY ROMAN V
      权利人:COLLEGIUM PHARMACEUTICAL INC
      摘要:One aspect of the present invention relates to methods for synthesizing milnacipran or congeners thereof. Another aspect of the present invention relates to asymmetric methods for synthesizing enantiomerically enriched milnacipran or congeners thereof. The present invention also relates to methods for synthesizing intermediates useful in the non-asymmetric or asymmetric methods for synthesizing enantiomerically enriched milnacipran or congeners thereof.

      专利号:US-6787668-B2
      优先权日:2000-04-13
      标 题 :2-amino-4,5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
      发明人:PITZELE BARNETT S; SIKORSKI JAMES A; WEBBER RONALD KEITH
      权利人:PHARMACIA CORP
      摘要:The present invention is directed to a compound of formula I:or a pharmaceutically acceptable salt thereof, wherein:R1 is selected from the group consisting of H and methyl; andR2 is selected from the group consisting of H and methyl.The compounds possess useful nitric oxide synthetase inhibiting activity, and are expected to be useful in the treatment or prophylaxis of a disease or condition in which the synthesis or over synthesis of nitric oxide forms a contributory part.

      专利号:WO-2009094569-A2
      优先权日:2008-01-25
      标 题:Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates

      专利号:WO-0134561-A1
      优先权日:1999-11-06
      标 题:Processes for the preparation of sumatriptan and related compounds
      发明人:HOLMAN NICHOLAS JOHN; FRIEND CHRISTOPHER LYNDON
      权利人:KNOLL AG; HOLMAN NICHOLAS JOHN; FRIEND CHRISTOPHER LYNDON
      摘要:The present invention relates to a process for preparing phenylhydrazines of formula (I) in which R represents CH2SO2NHCH3, CH2CH2SO2Ph, CH2CH2SO2NHMe or a group of structure (A), (B), (C), in which a diazonium salt of formula (II) in which X represents an anion derived from hydrochloric acid, sulphuric acid, acetic acid, phosphoric acid, tetrafluoroboric acid or hydrobromic acid is reduced by a dithionite salt. The resulting phenylhydrazines can be converted to the corresponding indole derivatives by the Fischer indole synthesis.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Allais G, Benedetto C. Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine. Drug Des Devel Ther. 2016 Oct 3;10:3225-3236. eCollection 2016. Review.
      2: Saracheva KE, Prissadova NA, Turiiski VI, Slavchev VI, Krastev AD, Getova DP. Effects of the Novel High-affinity 5-HT(1B/1D)-receptor Ligand Frovatriptan on the Rat Carotid Artery. Folia Med (Plovdiv). 2017 Mar 1;59(1):31-36. doi: 10.1515/folmed-2017-0006. doi: 10.1177/0333102415596443. Epub 2015 Jul 13. doi: 10.2147/PPA.S85795. eCollection 2016. Review.
      5: Allais G, Bussone G, Tullo V, Cortelli P, Valguarnera F, Barbanti P, Sette G, D'Onofrio F, Curone M, Benedetto C. Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial. Cephalalgia. 2015 Jan;35(1):45-50. doi: 10.1177/0333102414542290. Epub 2014 Jul 22.

      合成参考文献


      参考文献:10.1111/j.1742-1241.2011.02720.x
      摘要:Göbel H, Heinze A. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study. Int J Clin Pract. 2011 Aug;65(8):879–86. doi: 10.1111/j.1742-1241.2011.02720.x.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知